Development of Exosome Platform Technology to solve unmet medical needs
Even though transcription Factors show systemic efficacy, they cannot be made into drugs low stability in vivo.
SHIFTBIO can load transcription factors into exosomes in free-form and avoid the endosomal/lysosomal pathway through fusogenic peptides, thereby maximizing the efficiency of intracellular transcription factor delivery.
InProDel is a platform technology to automatically load free-form transcription factor inside the exosome and efficiently deliver into target cells.
Development of nanovesicle Platform Technology to solve unmet medical needs
Even though transcription Factors show systemic efficacy, they cannot be made into drugs low stability in vivo.
SHIFTBIO can load transcription factors into nanovesicles in free-form and avoid the endosomal/lysosomal pathway through fusogenic peptides,
thereby maximizing the efficiency of intracellular transcription factor delivery.
InProDel is a platform technology to automatically load free-form transcription factor
inside the nanovesicle and efficiently deliver into target cells.